12:00 AM
Apr 12, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

T-Spot: Post-marketing study data

A meta-analysis of 42,745 patients enrolled in 124 trials showed that QuantiFeron-TB Gold (QFT) and T-Spot.TB tuberculosis assays had higher specificity and sensitivity vs. the standard...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >